Compounds
    4.
    发明授权
    Compounds 失效
    化合物

    公开(公告)号:US06518286B1

    公开(公告)日:2003-02-11

    申请号:US09555565

    申请日:2000-06-01

    IPC分类号: C07D40112

    摘要: The invention provides compounds of general formula (I) wherein: R1 represents optionally substituted, C1-C12 alkyl or optionally substituted 3- to 10-membered saturated or unsaturated ring system comprising up to two ring carbon atoms that form carbonyl groups and comprising up to 4 ring heteroatoms independently selected from nitrogen, oxygen and sulfur; m is 0-1; Q represents OCH2, C1-C4 alkylene or C2-C4 alkenylene; T represents C(O)NH, or when m is 0, T may additionally represent a bond or NH, or when m is 1 and Q represents C1-C4 alkylene, T may additionally represent NH; n is 1-4; each R2 and R3 independently represents H or C1-C4 alkyl; V represents N, and W represents N or CH; X represents O, C(O), CH(OH), SO2, NH or N(C1-C6 alkyl), provided that when W represents N, then X represents either C(O) or SO2 and when W represents CH, then X is other than SO2; R4 represents optionally substituted phenyl; R5 and R6 each independently represent H, C1-C6 alkyl or hydroxyC1-C6 alkyl, or R5 and R6 together with the nitrogen atom to which they are attached form a 4- to 7-membered saturated heterocyclic ring; R7 and R8 each independently represent H or C1-C6 alkyl; and R9 represents OH or —NR7R8; processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

    摘要翻译: 本发明提供了通式(I)的化合物,其中:R 1表示任选取代的C 1 -C 12烷基或任选取代的3至10元饱和或不饱和环体系,其包含至多两个形成羰基的环碳原子, 独立地选自氮,氧和硫的4个环杂原子; m为0-1; Q表示OCH 2,C 1 -C 4亚烷基或C 2 -C 4亚烯基; T表示C(O)NH,或当m为0时,T可另外表示键或NH,或当m为1且Q表示C1-C4亚烷基时,T可另外表示NH; n为1-4; 每个R 2和R 3独立地表示H或C 1 -C 4烷基; V表示N,W表示N或CH; X表示O,C(O),CH(OH),SO 2,NH或N(C 1 -C 6烷基),条件是当W表示N时,X表示C(O)或SO 2,当W表示CH时, X不是SO2; R 4表示任选取代的苯基; R 5和R 6各自独立地表示H,C 1 -C 6烷基或羟基C 1 -C 6烷基,或者R 5和R 6与它们所连接的氮原子一起形成4-至7-元饱和杂环; R 7和R 8各自独立地表示H或C 1 -C 6烷基; 并且R 9表示OH或-NR 7 R 8; 其制备方法,含有它们的药物组合物及其在治疗中的用途。

    9-substituted 8-oxoadenine compound
    10.
    发明授权
    9-substituted 8-oxoadenine compound 有权
    9-取代的8-氧代腺嘌呤化合物

    公开(公告)号:US08012964B2

    公开(公告)日:2011-09-06

    申请号:US10593691

    申请日:2005-03-24

    摘要: The present invention provides an 8-oxoadenine compound having immunemodulating activities such as an interferon inducing activity and useful as an antiviral agent and antiallergic agent, which is represented by the following formula (1): [wherein the ring A represents a 6-10 membered aromatic carbocyclic ring and the like, R represents a halogen atom, an alkyl group and the like, n represents an integer of 0-2, Z1 represents alkylene, X2 represents oxygen atom, sulfur atom, SO2, NR5, CO, CONR5, NR5CO and the like, Y1, Y2 and Y3 represent independently a single bond or an alkylene group, X1 represents oxygen atom, sulfur atom, NR4 (R4 is hydrogen atom or an alkyl group) or a single bond, R2 represents a substituted or unsubstituted alkyl group, R1 represents hydrogen atom, hydroxy group, an alkoxy group, an alkoxycarbonyl group or a haloalkyl group] or its pharmaceutically acceptable salt.

    摘要翻译: 本发明提供具有免疫调节活性的8-氧代腺嘌呤化合物,例如干扰素诱导活性,可用作抗病毒剂和抗变应性剂,其由下式(1)表示:[其中环A表示6-10元 芳香族碳环等,R表示卤素原子,烷基等,n表示0-2的整数,Z1表示亚烷基,X2表示氧原子,硫原子,SO2,NR5,CO,CONR5,NR5CO 等等,Y1,Y2和Y3独立地表示单键或亚烷基,X1表示氧原子,硫原子,NR4(R4是氢原子或烷基)或单键,R2表示取代或未取代的烷基 基团,R 1表示氢原子,羟基,烷氧基,烷氧基羰基或卤代烷基]或其​​药学上可接受的盐。